Clinical Trials Browser

Neoplasms × Imatinib Mesylate × Other hematologic neoplasm × Clear all

Leukemia, Neoplasms, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Hematologic Neoplasms

NCT01650805 2014-11-17

Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)

LymphoidMyeloidOther hematologic neoplasm

Bone Marrow Diseases, Hematologic Diseases, Immune System Diseases, Immunoproliferative Disorders, Leukemia, Leukemia, Myeloid, Lymphatic Diseases, Lymphoproliferative Disorders, Myeloproliferative Disorders, Neoplasms, Neoplasms by Histologic Type, Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT00250042 2011-09-20

A Phase II Study of Gleevec and Arsenic Trioxide in Patients With CML Who Fail Gleevec

Phase 2 Completed

6 enrolled

Other hematologic neoplasm

Leukemia, Neoplasms

Clinical Trials

CARCML

Ponatinib in Newly Diagnosed Chronic Myeloid Leukemia (CML) (EPIC)

A Phase II Study of Gleevec and Arsenic Trioxide in Patients With CML Who Fail Gleevec